UAE to roll out new drug that reduces Covid-19 deaths, infections

  DUBAI – A new drug to treat unvaccinated Covid-19 patients and reduce Covid-related deaths and infections is expected to be approved for use in UAE hospitals soon. The Department of Health Abu Dhabi has announced that it has bought the AZD7442 drug made by AstraZeneca. The new antibody drug fights infections in high-risk patients. The drug has undergone clinical trials, with data showing that AZD7442 reduced the risk of developing Covid symptoms by 77 percent. AstraZeneca released the results of the trials in August. “When approved, this medication will help immunocompromised patients who could not receive the vaccine due to medical reasons and limiting autoimmune disorders,” said Dr Jamal Al Kaabi, undersecretary of the Department of Health Abu Dhabi. The UAE is one of the first countries to receive the medicine for those with various immune disorders who are not able to take the Covid-19 vaccine. People with chronic disease and autoimmune disorders will be the priority once the drug is approved for use in the UAE. ICA/Expat Media
For all the latest news from the UAE and the world, follow us on Facebook, Twitter and Instagram and subscribe to our YouTube pageJTNDc2NyaXB0JTIwc3JjJTNEJTIyJTJGJTJGcGFnZWFkMi5nb29nbGVzeW5kaWNhdGlvbi5jb20lMkZwYWdlYWQlMkZqcyUyRmFkc2J5Z29vZ2xlLmpzJTIyJTIwYXN5bmMlM0QlMjIlMjIlM0UlM0MlMkZzY3JpcHQlM0UlMEElMjAlM0MlMjEtLSUyMGluLWFydGljbGUlMjBhZCUyMC0tJTNFJTBBJTIwJTNDaW5zJTIwY2xhc3MlM0QlMjJhZHNieWdvb2dsZSUyMiUyMHN0eWxlJTNEJTIyZGlzcGxheSUzQSUyMGJsb2NrJTNCJTIyJTIwZGF0YS1hZC1jbGllbnQlM0QlMjJjYS1wdWItNTAwNjI0MTU4MzU4MTg0OSUyMiUyMGRhdGEtYWQtc2xvdCUzRCUyMjg1MjYwOTM2MTElMjIlMjBkYXRhLWFkLWZvcm1hdCUzRCUyMmF1dG8lMjIlM0UlM0MlMkZpbnMlM0UlMEElM0NzY3JpcHQlM0UlMkYlMkYlMjAlM0MlMjElNUJDREFUQSU1QiUwQSUyOGFkc2J5Z29vZ2xlJTIwJTNEJTIwd2luZG93LmFkc2J5Z29vZ2xlJTIwJTdDJTdDJTIwJTVCJTVEJTI5LnB1c2glMjglN0IlN0QlMjklM0IlMEElMkYlMkYlMjAlNUQlNUQlM0UlM0MlMkZzY3JpcHQlM0UlMEE=